EU drug regulator considers AstraZeneca accelerator

Europe’s drug regulator has confirmed that it is now considering whether to grant AstraZeneca’s vaccine authorization to be used as a COVID-19 boost.

AstraZeneca is expected to present data to support the extension of its use, and the European Medicines Agency to determine whether more evidence is needed for authorization.

.

Leave a Comment